A groundbreaking study has revealed a surprising biochemical connection between plant immune responses and human neurological health. Researchers have discovered that the metabolic pathways regulating ...
Researchers have introduced genetic material into plants via their roots, opening a potential pathway for rapid crop improvement.
Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.
The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.
Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...
From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...
AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...
“We recognize that those with rare diseases often have complex needs that go unmet by traditional assistance,” said Green.
The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback